Source comparison
Best CJC-1295 Dosage Fat Loss 2026: Comparison
This table compares dosing approaches, expected IGF-1 response, and practical trade-offs between CJC-1295 forms used in fat loss research protocols. | Form | Typical Dosage | Injection Frequency | IGF-1 Elevation (Week 4) | Pulsatility Preservation | Washout P
This comparison does not assign a generated winner or score.
- This table compares dosing approaches, expected IGF-1 response, and practical trade-offs between CJC-1295 forms used in fat loss research protocols.
- | Form | Typical Dosage | Injection Frequency | IGF-1 Elevation (Week 4) | Pulsatility Preservation | Washout Period | Professional Assessment ||—|—|—|—|—|—|| CJC-1295 with DAC | 1–2 mg weekly | Once per week | +250–350 ng/mL | Low. Receptor downregulation occurs | 4–6 weeks | Convenient dosing but higher metabolic adaptation risk; requires longer breaks between cycles || CJC-1295 without DAC (Modified GRF 1-29) | 100–300 mcg per injection | 2–3× per week | +150–250 ng/mL | High. Natural pulse architecture maintained | 1–2 weeks | More injections required but preserves endogenous GH function; better long-term sustainability || CJC-1295 without DAC + Ipamorelin | 100–200 mcg CJC + 100–200 mcg Ipamorelin | 2–3× per week (combined) | +200–300 ng/mL | Very High. Dual-pathway amplification | 1–2 weeks | Synergistic effect allows lower individual doses; minimal ghrelin rebound compared to GHRP-6 |